27 September 2022
This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
Location Sciences Group PLC
("Location Sciences" or the "Company" or the "Group")
Interim Results for the six months ended 30 June 2022
Location Sciences (AIM: LSAI), the leading location data insight and verification company, announces its interim results for the six months ended 30 June 2022.
CHAIRMAN'S REPORT FOR THE PERIOD ENDED 30 JUNE 2022
Introduction
Following the funding round in May 2021 which introduced new strategic investors to the shareholder register and two new Board members, the executive team successfully exited the location insights space, selling the Group's insights dashboard and certain customer contracts to Digital Envoy, Inc, a leading US IP intelligence business for US$700,000.
The proceeds from the aforementioned sale and the Group's share placing in May 2021, which raised approximately £3.74 million (before expenses), provided the Group with a solid financial platform from which to increase shareholder value which management and the Board are fully engaged in. As at 30 June 2022, the net current assets of the Company were £4.4 million, including net cash of £4,227,685.
Trading performance
Unaudited revenues for the six months ended 30 June 2022 were £145,430, which included £99,022 of earn-out income from the sale of the Insights business during 2021. Underlying Verify revenues were £46,408 in the period, representing a decrease of 9% compared to H1 2021 revenues of £50,968.
Administration expenses were £489,552 in H1 2022 compared to £429,652 in H1 2021. The increase of 14% in administration expenses is due to the impact of fee shares issued to the non-executive directors in the period and was not a cash cost to the Company. Cash costs have been reduced during the period with a number of staff cuts and overhead reductions being implemented by the Board.
EBITDA loss for the six months to 30 June 2022 was £362,809, representing a decrease of 10% on the EBITDA loss in the six months to 30 June 2021 of £404,628.
Loss before tax for the six months to 30 June 2022 was £492,353, representing an decrease of 7% on the loss before tax in the six months to 30 June 2021 of £527,237.
Outlook
The Board continues to review how best to maximise the value of the Company's assets and will update shareholders in due course.
Simon Wilkinson
Chairman
LOCATION SCIENCES GROUP PLC
CONSOLIDATED PROFIT AND LOSS ACCOUNT FOR THE PERIOD ENDED 30 JUNE 2022
| Note | Six months | Six months | Year ended |
Revenue | 4 | 145,430 | 50,968 | 167,940 |
Cost of sales | | (18,686) | (25,944) | (77,243) |
Gross profit | | 126,743 | 25,024 | 90,697 |
Grant income | | - | - | - |
Other income | | - | - | 11,267 |
Administrative expenses | | (489,552) | (429,652) | (801,432) |
Amortisation and depreciation | | (130,524) | (122.610) | (216,392) |
Exceptional administrative expenses | | - | - | (283,210) |
Operating loss | 4 | (493,333) | (527,238) | (1,199,070) |
Finance income | | 980 | 1 | 2 |
Finance expense | | - | - | - |
Loss before tax | | (492,353) | (527,237) | (1,199,068) |
Taxation | | - | 71,514 | 113,871 |
Loss for the financial year from continuing operations | | (492,353) | (455,723) |
(1,085,197) |
Discontinued Operations | | | | |
Loss for the year from discontinued operations | | - | (163,613) |
(298,161) |
Loss for the financial year | | (492,353) | (619,336) | (1,383,358) |
Earnings per share | | | | | |
Loss per share - basic and diluted | (0.02p) | (0.06p) | (0.076p) | |
|
The above results were derived from continuing operations.
LOCATION SCIENCES GROUP PLC
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME FOR THE PERIOD ENDED 30 JUNE 2022
| Six months | Six months | Year ended | |||
Loss for the year | (492,353) | (619,336) | (1,383,358) |
| ||
Foreign currency translation losses | - | (4,719) | (4,718) |
| ||
Total comprehensive income for the year attributable to owners of the company | (492,353) | (624,055) | (1,388,076) |
| ||
LOCATION SCIENCES GROUP PLC
CONSOLIDATED BALANCE SHEET AS AT 30 JUNE 2022
| Note | 30 June | 30 June | 31 December Audited |
|
Non-current assets | | | | |
|
Intangible assets | | 406,967 | 1,153,954 | 537,491 |
|
Property, plant and equipment | | - | 3,198 | - |
|
| | | 1,157,152 | 537,491 |
|
Current assets | | | | |
|
Trade and other receivables | | 259,564 | 505,232 | 331,559 |
|
Current tax asset | | 113,871 | 71,514 | 113,871 |
|
Cash and cash equivalents | | 4,227,685 | 4,333,115 | 4,378,825 |
|
| | 4,601,120 | 4,909,861 | 4,824,255 |
|
Current liabilities | | | | |
|
Trade and other payables | | (202,088) | (148,577) | (183,175) |
|
| | (202,088) | (148,577) | (183,175) |
|
Net current assets | | 4,399,032 | 4,761,284 | 4,641,080 |
|
Net assets | | 4,805,999 | 5,918,436 | 5,178,571 |
|
Capital and reserves | | | | |
|
Called up share capital | 5 | 16,340,507 | 16,298,007 | 16,298,007 | |
Share premium reserve | | 20,088,118 | 21,170,312 | 20,034,993 |
|
Merger relief reserve | | 11,605,556 | 11,605,556 | 11,605,556 |
|
Capital reserve | | 209,791 | 209,791 | 209,791 |
|
Other reserves | | (9,225,108) | (9,225,108) | (9,225,108) |
|
Equity Reserve | | 1,135,319 | - | 1,135,319 |
|
Retained earnings | | (35,348,184) | (34,140,122) | (34,879,987) |
|
Total equity | | 4,805,999 | 5,918,436 | 5,178,571 |
|
LOCATION SCIENCES GROUP PLC
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 30 JUNE 2022
EQUITY ATTRIBUTABLE TO THE PARENT COMPANY
| Share capital | Share premium | Merger relief reserve | Capital reserve | Reverse acquisition reserve |
Equity reserve | Retained earnings | Total |
At 1 January 2021 | 14,280,258 | 19,315,231 | 11,605,556 | 209,791 | (9,225,108) | - | (33,540,223) | 2,645,505 |
Loss for the period | - | - | - | - | - | - | (619,336) | (619,336) |
Other comprehensive income | - | - | - | - | - | - | (4,719) | (4,719) |
Issue of shares | 2,017,749 | 1,855,081 | - | - | - | - | - | 3,872,830 |
Share based payments | - | - | - | - | - | - | 24,156 | 24,156 |
At 30 June 2021 | 16,298,007 | 21,170,312 | 11,605,556 | 209,791 | (9,225,108) | - | (34,140,122) | 5,918,436 |
At 1 January 2021 | 14,280,258 | 19,315,231 | 11,605,556 | 209,791 | (9,225,108) | - | (33,540,223) | 2,645,505 |
Loss in year | - | - | - | - | - | - | (1,383,358) | (1,383,358) |
Other Comprehensive Income | - | - | - | - | - | - | (4,718) | (4,718) |
Issues of shares | 2,017,749 | 1,855,081 | - | - | - | - | - | 3,872,830 |
Warrants issued | - | (1,135,319) | - | - | - | 1,135,319 | - | - |
Share based payments | - | - | - | - | - | - | 48,312 | 48,312 |
At 31 December 2021 | 16,298,007 | 20,034,993 | 11,605,556 | 209,791 | (9,225,108) |
1,135,319 | (34,879,987) | 5,178,571 |
At 1 January 2022 | 16,298,007 | 20,034,993 | 11,605,556 | 209,791 | (9,225,108) | 1,135,319 | (34,879,987) | 5,178,571 |
Loss for the period | - | - | - | - | - | - | (492,353) | (492,353) |
Other comprehensive income | - | - | - | - | - | - | - | - |
Issue of shares | 42,500 | 53,125 | - | - | - | - | - | 95,625 |
Share based payments | - | - | - | - | - | - | 24,156 | 24,156 |
At 30 June 2022 | 16,340,507 | 20,088,118 | 11,605,556 | 209,791 | (9,225,108) | 1,135,319 | (35,348,184) | 4,805,999 |
LOCATION SCIENCES GROUP PLC
CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30 JUNE 2022
| Note | Six months | Six months | Year ended |
Cash flows from operating activities | ||||
Loss for the year from continuing activities | | (492,353) | (455,723) | (1,085,197) |
Loss for the year from discontinued activities | | - | (163,613) | (298,161) |
Adjustments to cash flows from non-cash items: | | | | |
Depreciation and amortisation | | 130,524 | 204,351 | 508,862 |
Impairment charge | | - | - | 283,210 |
Foreign exchange (gains) / losses | | - | (4,719) | (4,718) |
Finance income | | (980) | (1) | (2) |
Finance costs | | - | - | - |
Share based payment transactions | | 24,156 | 24,156 | 48,312 |
Income tax expense | | - | (71,514) | (113,871) |
Up lift in fair value of directors' fees | | 10,625 | 195,500 | 195,500 |
Shares issued other than for cash | | 85,000 | 120,000 | 120,000 |
| | (243,028) | (151,563) | (636,705) |
Working capital adjustments | | | | |
Decrease in trade debtors | | 71,995 | (90,128) | 88,225 |
Increase in trade creditors | | 18,913 | (62,480) | (33,114) |
Cash used in operations | | (152,120) | (304,171) | (581,594) |
Income taxes received | | - | 166,272 | 166,272 |
Net cash used in operating activities | | (152,120) | (137,899) | (415,322) |
Cash flows from investing activities | | | | |
Interest received | | 980 | 1 | 2 |
Disposals of discontinued operations | | - | - | 450,138 |
Acquisitions of tangible assets | | - | - | - |
Acquisition of intangible assets | | - | (214,435) | (341,441) |
Net cash used in investing activities | | 980 | (214,434) | (108,699) |
Cash flows from financing activities | | | | |
Proceeds from issue of ordinary shares, net of issue costs | | - | 3,557,330 | 3,557,330 |
Net cash generated from financing activities | | - | 3,557,330 | 3,557,330 |
Net (decrease)/increase/ in cash and cash equivalents | | (151,140) | 3,204,997 | 3,250,707 |
Cash and cash equivalents at beginning of period | | 4,378,825 | 1,128,118 | 1,128,118 |
Cash and cash equivalents at end of period | | 4,227,685 | 4,333,115 | 4,378,825 |
| | | | |
| Note | Six months | Six months | Year ended |
Non-cash financing activities | | | | |
Share warrants exercised in period | | - | - | 10,000 |
Fees settled by share issues | | - | 265,500 | 120,000 |
Directors' fees settled by share issues | | 95,625 | 280,500 | 163,625 |
LOCATION SCIENCES GROUP PLC
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 JUNE 2022
1 General information
Location Sciences Group PLC and its subsidiary Location Sciences AI Limited (together the "Group") provide location verification services, utilising sophisticated machine learning and pattern recognition technologies Verify detects location ad-fraud and checks the accuracy and quality of location signals used to improve the performance of digital advertising.
The Company is a public limited company which is quoted on the AIM market of the London Stock Exchange and is incorporated and domiciled in the United Kingdom.
2 Basis of preparation
The financial information has been prepared in accordance with International Financial Reporting Standards ("IFRS") as adopted by the European Union, IFRIC interpretations and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The accounting policies adopted are consistent with those of the financial statements for the year ended 31 December 2021, as described in those financial statements.
The figures for the six-month periods ended 30 June 2022 and 30 June 2021 have not been audited. The figures for the year ended 31 December 2021 have been extracted from, but do not constitute, the consolidated financial statements of Location Sciences Group PLC for that year. Those financial statements have been delivered to the Registrar of Companies and included an unqualified auditors' report and did not contain a statement under Section 498(2) or Section 498(3) Companies Act 2006.
3 Loss per share
| Six months | Six months | Year ended |
Loss attributable to shareholders | (492,353) | (619,336) | (1,383,358) |
| No. | No. | No. |
Weighted average number of shares (basic) | 2,611,934,620 | 990,887,398 | 1,814,571,645 |
The calculation of basic loss per share of 0.02p (June 2021: 0.06p; December 2021: 0.076p) is based on loss after taxation and the weighted average number of ordinary shares in issue during the period.
4 Segmental analysis
Operating segments are based on internal reports about components of the Company, which are regularly reviewed and used by the Board of Directors being the Chief Operating Decision Maker ("CODM") for strategic decision making and resource allocation, in order to allocate resources to the segment and to assess its performance.
During the first half of 2022 the Group has operated through its trading company Location Sciences AI Limited. The business provides location verification services, utilising sophisticated machine learning and pattern recognition technologies Verify detects location ad-fraud and checks the accuracy and quality of location signals used to improve the performance of digital advertising.
It should be noted that a segmental analysis of the Consolidated Statement of Financial Position is not part of routine management reporting and, consequently, no segmental analysis of assets is shown here.
An analysis of operating revenue is as follows:
| Six months | Six months | Year ended |
Location data and insights* | - | 226,986 | 373,448 |
Verify | 145,430 | 50,968 | 167,940 |
| 145,430 | 277,954 | 541,388 |
*disclosed within discontinued operations
An analysis of EBITDA is as follows:
| Six months | Six months | Year ended |
Location data and insights | - | (397,291) | (299,972) |
Verify | 362,809 | (89,209) | (682,706) |
| 362,809 | (486,500) | (982,678) |
An analysis of loss before tax is as follows:
| Six months | Six months | Year ended |
Location data and insights | - | (236,847) | (298,161) |
Verify | (492,353) | (454,003) | (1,199,098) |
| (492,353) | (690,850) | (1,497,229) |
5 Share capital
| 30 June | 30 June | 31 December |
2,647,587,398 ordinary shares of 0.1p (June 2021 - 2,605,087,398 of 0.1p, December 2021 2,605,087,398 of 0.1p) each | 2,647,587 | 2,605,087 | 2,605,087 |
1,040,712,398 deferred shares of 0.99p each | 10,303,054 | 10,303,054 | 10,303,054 |
376,651,734 New Deferred shares of 0.9p each | 3,389,866 | 3,389,866 | 3,389,866 |
| 16,340,507 | 16,298,007 | 16,298,007 |
Share issue
On 1 June 2022 42,500,000 ordinary shares of 0.1p were issued at 0.2p per ordinary share to the non-executive directors in settlement of their second-year fees.
Share rights
Ordinary shares have attached to them full voting, dividend and capital distribution (including on winding up) rights; they do not confer any rights of redemption.
Deferred shares have attached to them no voting, dividend or capital distribution (including on winding up) rights; they do not confer any rights of redemption.
Warrants in Issue
1) Promoter Warrants - non-transferable warrants to subscribe for up to 1,500,000,000 Ordinary Shares, exercisable at the 0.20p for five years from 25 May 2021, were issued to certain members of the Concert Party in consideration of those persons assembling and co-ordinating the Concert Party's investment in the Company in May 2021 and facilitating the appointment of Simon Wilkinson as Non-Executive Chairman.
Name Number of Ordinary Shares subject to Promoter Warrants
Richard Hughes 500,000,000
Mahmud Kamani 500,000,000
Simon Wilkinson 500,000,000
2) Cornerstone Investor Warrants - non-transferable warrants to subscribe for up to 250,000,000 Ordinary Shares, exercisable at 0.20p for five years from 25 May 2021, were issued to the Cornerstone Investors of the May 2021 placing.
Name Number of Ordinary Shares subject to Cornerstone Investor Warrants
Ben Turner 50,000,000
Donna Turner 75,000,000
James Pope 50,000,000
Maxine Pope 75,000,000
3) Broker Warrants - transferable warrants to subscribe for up to 100,000,000 Ordinary Shares, exercisable at the 0.20p for five years from 25 May 2021 were issued as shown below.
Name Number of Ordinary Shares subject to Broker Warrants
Turner Pope 58,750,000
Dr Nigel Burton 25,000,000
Mark Slade 10,000,000
David Rae 6,250,000
4) Director Warrants - non-transferable warrants to subscribe for, in aggregate, 120,000,000 Ordinary Shares were issued to the Executive Directors and the Non-Executive Directors, exercisable at 0.20p for five years from 25 May 2021, provided that the Ordinary Shares have traded at a Volume Weighted Average Price (VWAP) at or above 0.30p for 20 consecutive Business Days, or on a change of control of the Company.
Name Number of Ordinary Shares subject to Broker Warrants
Mark Slade 30,000,000
David Rae 30,000,000
Simon Wilkinson 30,000,000
Dr Nigel Burton 30,000,000
6 Availability of half-year report
Copies of the half-year report are available on request from the Company's registered office at First Floor, St James House, St James Square, Cheltenham, Gloucestershire GL50 3PR and can also be viewed at:
https://www.locationsciencesgroup.ai/investor-relations/reports-presentations/
For further information please contact:
Location Sciences Group PLC via Allenby Capital
Simon Wilkinson, Chairman
Allenby Capital Limited (Nominated Adviser) Tel: +44 (0)20 3328 5656
David Hart
Vivek Bhardwaj
Turner Pope Investments (TPI) Ltd (Broker) Tel: +44 (0)20 3657 0050
James Pope
Andy Thacker
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.